Atsushi Kondo

Atsushi Kondo

Auto-generated profile, based on publicly available information

Atsushi Kondo

Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AKAtsushi Kondo
Atsushi Kondo
CNChina Nagano
China Nagano
SIShinya Ishiko
Shinya Ishiko
TOTakashi Omori
Takashi Omori
YAYuya Aoto
Yuya Aoto
KNKandai Nozu
Kandai Nozu
Gitelman syndrome is an autosomal recessive inherited salt-losing tubulopathy. It has a prevalence of around 1 in 40,000 people, and heterozygous carriers are estimated at approximately 1%, although the exact prevalence is unknown. We estimated the predicted prevalence of Gitelman syndrome based on multiple genome databases, HGVD and jMorp for the Japanese population and gnomAD for other ethnicities, and included all 274 pathogenic missense or nonsense variants registered in HGMD Professional. The frequencies of all these alleles were summed to calculate the total variant allele frequency in SLC12A3. The carrier frequency and the disease prevalence were assumed to be twice and the square of the total allele frequency, respectively, according to the Hardy–Weinberg principle. In the Japanese population, the total carrier frequencies were 0.0948 (9.5%) and 0.0868 (8.7%) and the calculated prevalence was 0.00225 (2.3 in 1000 people) and 0.00188 (1.9 in 1000 people) in HGVD and jMorp, respectively. Other ethnicities showed a prevalence varying from 0.000012 to 0.00083. These findings indicate that the prevalence of Gitelman syndrome in the Japanese population is higher than expected and that some other ethnicities also have a higher prevalence than has previously been considered.

1 May 2019 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
TYTomohiko Yamane
Tomohiko Yamane
AKAtsushi Kondo
Atsushi Kondo
MTMasafumi Takahashi
Masafumi Takahashi
YMYuuki Miyazaki
Yuuki Miyazaki
TEToshihiko Ehara
Toshihiko Ehara
IMIchiro Matsunari
Ichiro Matsunari

HYHiroshi Yamaguchi
Hiroshi Yamaguchi
KNKandai Nozu
Kandai Nozu
SIShinya Ishiko
Shinya Ishiko
AKAtsushi Kondo
Atsushi Kondo
TNTakeshi Ninchoji
Takeshi Ninchoji
AIAkihito Ishida
Akihito Ishida
The coronavirus disease (COVID-19) pandemic altered environmental factors. We studied the impact of these changes on asthma exacerbation (AE) by comparing the AE-related environmental factors between COVID-19 (2020) and pre-COVID-19 (2011–2019) eras. Between 2011 and 2020, 278,465 children (<16 years old) visited our emergency department, and 7476 were diagnosed with AE. The number of patients showed spring and fall peaks in 2011–2019. Multivariate analyses showed significant positive relationships of the number of AE patients with the average temperature among all patients and 0–5-year-olds and with sulfur dioxide (SO2) levels in 2011–2019 among 0–5-year-olds. Although the spring peak in the number of patients was not observed in 2020 after declaration of a state of emergency, the fall peak was again observed after the state of emergency was lifted. No changes in average temperature were detected, but SO2 was significantly reduced following declaration of the state of emergency in 2020. Therefore, SO2 reduction might have contributed to the disappearance of the peak of AE. However, a fall peak was observed again in 2020, although SO2 levels continued to be low. These data suggest that person to person interaction seems to be associated with AE, presumably due to unknown viral infections.

1 November 2016 in Anticancer Research
Verified
Journal Article
Open access
PDF file
KTKenichi Takano
Kenichi Takano
TKTakuya Kakuki
Takuya Kakuki
KOKazufumi Obata
Kazufumi Obata
KNKazuaki Nomura
Kazuaki Nomura
RMRyo Miyata
Ryo Miyata
TKTakashi Kojima
Takashi Kojima
Background/Aim: Lipolysis-stimulated lipoprotein receptor (LSR) knockdown has also been reported to increase the motility and invasiveness of certain cancer cells. Here, we describe, for the first time, the behavior and role of LSR in head and neck squamous cell carcinoma (HNSCC) in vivo and in vitro. Materials and Methods: Samples of HNSCC, normal palatine tonsils, the pharynx carcinoma cell line Detroit562 and primary cultured HNSCC were characterized by immunostaining, western blot, real-time polymerase chain reaction (PCR), Matrigel invasion and proliferation assays. Results: Protein and mRNA of LSR were strongly expressed, as well as claudin-1 in HNSCC tissues than in normal tissues, especially in invasive tissues. Knock-down of LSR and claudin-1 (CLDN-1), but not tricellulin (TRIC) by siRNAs, markedly induced invasiveness of Detroit562 cells and primary cultured HNSCC. LSR inhibited the development and progression of HNSCC. Conclusion: LSR is a potential target for new forms of head and neck cancer therapy.

11 January 2022 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
SNSadayuki Nagai
Sadayuki Nagai
THTomoko Horinouchi
Tomoko Horinouchi
TNTakeshi Ninchoji
Takeshi Ninchoji
AKAtsushi Kondo
Atsushi Kondo
YAYuya Aoto
Yuya Aoto
KNKandai Nozu
Kandai Nozu

2 February 2024 in CEN Case Reports
Verified
Journal Article
Closed access
PDF file
AKAtsushi Kondo
Atsushi Kondo
KYKunihiko Yoshiya
Kunihiko Yoshiya
NSNana Sakakibara
Nana Sakakibara
CNChina Nagano
China Nagano
THTomoko Horinouchi
Tomoko Horinouchi
KNKandai Nozu
Kandai Nozu